Instruction for use: Trimex

ATX Code R01BA01 Phenylpropanolamine

Pharmacotherapeutic group:

Alpha-adrenoceptor agonists

Regulators appetite

The nosological classification (ICD-10)

E66 Obesity

Adipoz, overweight, Overweight, Constitutional tendency to obesity, Obesity or overweight, Increased body weight, Tendency to corpulence, Reducing overweight, Exogenous constitutional obesity,Inclined to corpulence

Composition

1 tablet contains 75 mg of phenylpropanolamine hydrochloride; in blister 20 pcs.

pharmachologic effect

anorectic.

It inhibits the excitability of the alimentary center, has sympathomimetic properties.

Indications of Trimex

Alimentary obesity.

Contraindications

Hypersensitivity, hypertension, pregnancy, children's age (12 years).

Side effects

Increased irritability, dizziness, insomnia, tachycardia, headache.

Interaction

Incompatible with fenilalkilamina with antidepressants - MAO inhibitors.

Dosage and Administration

Inside - 1 table. After breakfast, a glass of water. In the older age groups of 68 years and from 12 to 18 years require individual dose adjustment.

Treatment: In case of nasal overdose should immediately wash or clean the nose. You may need symptomatic treatment.

Precautionary measures

With caution and under medical supervision used in diabetes, diseases of the thyroid gland and heart. Lactating women in the period of treatment should abandon breastfeeding.

Storage conditions of Trimex

At a temperature of 15-30 ° C.

Keep out of the reach of children.
Shelf life of Trimex

2 years.

Do not use beyond the expiration date printed on the package.